But Marc Hamilton, Ph.D., one of Katzmarkzyk's colleagues, suspects it has to do with an enzyme called lipoprotein lipase (LPL), which breaks down fat in the bloodstream and turns it into energy.
但是，凯茨玛德扎克的一个同事，马克·汉密尔顿博士怀疑，与一种叫脂蛋白脂肪酶(LPL)的酶有关，它能分解血管内的脂肪，将之转化为能量。
Insulin may also cause your body to produce more of an enzyme called lipoprotein lipase, which increases the uptake of fat into cells, leading to weight gain.
胰岛素也可能导致你的身体产生更多的脂蛋白脂肪酶，它能增加细胞里脂肪的吸收，从而增重。
Nor is lipoprotein lipase the only molecule affected by muscular inactivity.
脂朊脂酶并不是唯一受肌肉不活跃影响的分子。
Lipoprotein lipase (LPL) is a key enzyme of lipid metabolism, its primary function is the hydrolysis of the core triglycerides of circulating chylomicrons and very low density lipoproteins.
脂蛋白脂肪酶(LPL)是脂蛋白代谢的关键酶，LPL基因变异常可导致异常脂蛋白血症。
Objective To explore the gene expression of hormone sensitive lipase (HSL) and lipoprotein lipase (LPL) between obesity-prone (op) and obesity-resistant (or) rats induced by a high-fat diet.
目的探讨高脂饮食诱导肥胖易感(OP)大鼠和肥胖抵抗(OR)大鼠，激素敏感性脂肪酶(HSL)和脂蛋白脂肪酶(LPL)基因表达的差别。
The relationship between lipoprotein lipase (LPL) gene polymorphism and atherosclerotic diseases or stroke has become a topic of general interest in recent years.
脂蛋白脂酶（LPL）基因多态性与动脉粥样硬化性疾病或卒中的关系成为近年来的研究热点。
Conclusions Reduced activity of lipoprotein lipase and hepatic lipase is one of causes leading to hypertriglyceridemia in nephrotic syndrome.
结论肾病综合征脂蛋白脂酶和肝脂酶活性降低为高三酰甘油血症的病因之一。
But Marc Hamilton, Ph. D., one of Katzmarkzyk's colleagues, suspects it has to do with an enzyme called lipoprotein lipase (LPL), which breaks down fat in the bloodstream and turns it into energy.
但是，凯茨玛德扎克的一个同事，马克·汉密尔顿博士怀疑，与一种叫脂蛋白脂肪酶(LPL)的酶有关，它能分解血管内的脂肪，将之转化为能量。
Objective To study the expression of lipoprotein lipase(LPL) in human glomerular mesangial cells and the effect of very low-density lipoprotein(VLDL) on the expression of LPL.
目的探讨人肾小球系膜细胞脂蛋白脂酶（LPL）的表达情况以及极低密度脂蛋白（VLDL）对其表达的影响。
Lipoprotein Lipase (LPL) plays an important role in plasma lipoprotein metabolism.
脂蛋白脂肪酶(LPL)在血浆脂蛋白的代谢中发挥了重要的作用。
The first case of familial lipoprotein lipase (LPL) deficiency in China is re-ported.
本文报道了我国首例家族性脂蛋白脂酶缺乏症。
Context: Hepatic lipase influences metabolism of high-density lipoprotein (HDL), a risk factor for ischemic cardiovascular disease (ICD: ischemic heart disease and ischemic cerebrovascular disease).
背景：肝脂肪酶影响缺血性心血管病（ICD：缺血性心脏病及缺血性脑血管病）的危险因子HDL的代谢。
Conclusion HP infection might cause disorder in the lipid metabolism. The possible mechanism might be that the HP infection can suppress activity and secretion of lipoprotein lipase.
结论HP感染可引起脂代谢紊乱，可能机制为HP感染抑制了脂蛋白酶的活性与分泌。
CONCLUSION: Taizhi "an capsule can decrease the hyperlipidemia. Its mechanism is related to the regulation of lipid metabolism and improvement of the concentration of LPL (lipoprotein lipase)."
结论：泰脂安对高脂模型大鼠有较好的降脂作用，其降脂作用机制可能与泰脂安升高血清中的脂蛋白脂肪酶含量有关。
CLA may inhibit the enzymes, lipoprotein lipase(LPL), stearoyl-CoA desaturase(SCD), fatty acid synthase(FAS)and so on, which are related to lipid metabolism.
抑制脂肪代谢相关酶脂蛋白脂酶、硬脂酰辅酶A 脱氢酶、脂肪酸合成酶等的活性来产生降脂作用。
From the research in the abdominal obesity, we know it can be caused by many factors, such as the gene, age, energy intake, lipoprotein lipase (LPL) reactive and the lipolysis reactive.
腹型肥胖的发生与遗传、年龄、能量摄入、脂蛋白脂酶（LPL）活性及脂解活性等多种因素相关；
From the research in the abdominal obesity, we know it can be caused by many factors, such as the gene, age, energy intake, lipoprotein lipase (LPL) reactive and the lipolysis reactive.
腹型肥胖的发生与遗传、年龄、能量摄入、脂蛋白脂酶（LPL）活性及脂解活性等多种因素相关；
应用推荐